Trial intelligence / Profile preview

Quadrivalent versus trivalent inactivated influenza vaccine in children aged 3 to 8 years

2011-005374-33Phase 3Completed

Sponsor
Sanofi
Start
Apr 2013
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of influenza vaccine, trivalent influenza vaccine in influenza, sponsored by Sanofi. Started Apr 2013; status: completed.

02

Drugs

influenza vaccinetrivalent influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on 2011-005374-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005374-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call